- Obesity is ‘exploding,’ with more than 12% of people classified as obese worldwide, study finds: ‘Big trouble’ New York Post
- Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults The Lancet
- Obesity has become the most common form of malnutrition in the majority of countries EL PAÍS USA
- More than a billion people worldwide are obese, WHO study finds Reuters
- More than 1 billion people worldwide are now estimated to have obesity Science News Magazine
Tag Archives: obesity
Gene Linked to Mitochondrial Dysfunction in Obesity – Neuroscience News
- Gene Linked to Mitochondrial Dysfunction in Obesity Neuroscience News
- Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation Nature.com
- Obesity Held Back by Single Gene Deletion, Reversing Mitochondrial Fission in Mice Genetic Engineering & Biotechnology News
- How obesity dismantles our mitochondria: Study reveals key mechanism behind obesity-related metabolic dysfunction Medical Xpress
- Switching off a single gene could allow people to eat whatever they want without getting fat, study suggests Daily Mail
Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation – Nature.com
- Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation Nature.com
- Obesity Held Back by Single Gene Deletion, Reversing Mitochondrial Fission in Mice Genetic Engineering & Biotechnology News
- How obesity dismantles our mitochondria: Study reveals key mechanism behind obesity-related metabolic dysfunction Medical Xpress
- Obesity: How a single molecule may disrupt the body’s metabolism Medical News Today
- Switching off a single gene could allow people to eat whatever they want without getting fat, study suggests Daily Mail
Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds – KSL.com
- Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds KSL.com
- Novo Nordisk: Wegovy heart benefits due to more than weight loss Reuters
- Trial confirms heart benefits of Wegovy, but is weight loss responsible – or something else? CNN
- Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Shows The New York Times
- Novo Nordisk A/S: Semaglutide 2.4 mg (Wegovy®) cardiovascular outcomes data presented at American Heart Association Scientific Sessions and simultaneously published in New England Journal of Medicine Yahoo Finance
- View Full Coverage on Google News
Lilly’s next obesity drug just cut an average of 58 pounds—prompting an all-out phase 3 blitz – FierceBiotech
- Lilly’s next obesity drug just cut an average of 58 pounds—prompting an all-out phase 3 blitz FierceBiotech
- A new weight-loss drug dubbed the ‘triple G’ could be stronger than Ozempic, Wegovy, and Mounjaro — and as powerful as bariatric surgery Yahoo Life
- Eli Lilly (LLY) Weight-Loss Shot Gives Company’s Strongest Results in Trial Bloomberg
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Lancet
- Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | NEJM nejm.org
- View Full Coverage on Google News
Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug – STAT
- Fatty liver disease was alleviated by Lilly’s ‘triple-G’ obesity drug STAT
- A new weight-loss drug dubbed the ‘triple G’ could be stronger than Ozempic, Wegovy, and Mounjaro — and as powerful as bariatric surgery Yahoo Life
- Eli Lilly (LLY) Weight-Loss Shot Gives Company’s Strongest Results in Trial Bloomberg
- Triple Agonist Retatrutide Hits New Weight-Loss Highs Medscape
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Lancet
- View Full Coverage on Google News
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | NEJM – nejm.org
- Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | NEJM nejm.org
- Lilly links oral drug to 15% weight loss, setting bar for Pfizer FierceBiotech
- A new weight-loss drug dubbed the ‘triple G’ could be stronger than Ozempic, Wegovy, and Mounjaro — and as powerful as bariatric surgery Yahoo Life
- Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Lancet
- Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Medpage Today
- View Full Coverage on Google News
‘This is an emergency’: Dr Chris Van Tulleken on why ultra processed food fuels obesity, tooth decay and illness – Channel 4 News
- ‘This is an emergency’: Dr Chris Van Tulleken on why ultra processed food fuels obesity, tooth decay and illness Channel 4 News
- The most ultra processed foods experts say you should cut from your diet now Wales Online
- There is nothing healthy about our paranoia over ultra processed food The Telegraph
- I’m a dietitian – here’s the 9 worst ultra-processed foods ‘linked to silent killers’ and what to eat inste… The Sun
- Oh Good – Ultra-Processed Food Might Be Worse For Us Than We Thought HuffPost UK
- View Full Coverage on Google News
Meta’s stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market – MarketWatch
- Meta’s stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market MarketWatch
- Stocks making the biggest premarket moves: Meta, Rivian, WW International, KeyCorp and more CNBC
- 5 stocks to watch on Tuesday: Meta Platforms, Rivian and more (NASDAQ:META) Seeking Alpha
- Meta, Dick’s Sporting Goods and WW International rise premarket; Rivian falls By Investing.com Investing.com
- Stocks making the biggest moves midday: Rivian, Delta, Snap, Dish Network and more CNBC
- View Full Coverage on Google News
Obesity crisis is worsening heart disease risks during and after pregnancy: Experts – ABC News
- Obesity crisis is worsening heart disease risks during and after pregnancy: Experts ABC News
- High Blood Sugar: Gestational Diabetes And Preeclampsia May Slower Biological Development In Infants, Claim… Zee News
- Common pregnancy complications may be linked to slower biological development in infants News-Medical.Net
- IVF may double the risk of deadly pregnancy complications, study warns Daily Mail
- Study reveals gestational diabetes, pre-eclampsia linked to slower biological development in infants Indiatimes.com
- View Full Coverage on Google News